Tandem Diabetes Care fully repays term loan via Capital Royalty

By Marisa Wong

Morgantown, W.Va., Aug. 8 – Tandem Diabetes Care, Inc. announced it repaid in full its term loan from Capital Royalty Partners II LP and its affiliated funds.

The balance of the outstanding debt plus accrued interest was about $83.8 million, plus roughly $5 million in associated financing fees.

The interest rate on the term loan was 11.5%.

Tandem designs and sells products for people with diabetes who use insulin. The medical device company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.